返回 Agenda
Session Chair(s)
John A. Lisman, LLM, MPHARM
Advocaat/Attorney, Consultant, Trainer
Lisman Legal Life Sciences B.V., Netherlands
Speaker(s)
Off-Label Use from the Regulatory Perspective: A necessary evil or a blessing in disguise?
Yechiel Hekster
Medicines Evaluation Board, Netherlands
Professor of Clinical Pharmacy
Off-Label Use from the Industry Perspective: Walking a tight rope?
Hector Roethlisberger
Takeda Pharmaceuticals International GmbH, Switzerland
Corporate Counsel
Legal and Practical Aspects of Off-Label Use.
John A. Lisman, LLM, MPHARM
Lisman Legal Life Sciences B.V., Netherlands
Advocaat/Attorney, Consultant, Trainer